Retatrutide
Investigational triple agonist of the GIP, GLP-1, and glucagon receptors studied in metabolic research.
This material is sold strictly for laboratory and research use only. Not for human consumption, veterinary, clinical, or therapeutic use.
About Retatrutide
Investigational triple agonist of the GIP, GLP-1, and glucagon receptors studied in metabolic research.
Supplied as a sterile-filtered, lyophilized powder in a sealed glass vial. Reconstitution is performed by the researcher. A certificate of analysis confirming identity and purity is enclosed with every order.
This summary describes where the compound has appeared in published research. It is provided for scientific context only and is not a claim of efficacy.
Every batch, on record.
Each lot is independently characterised by HPLC and mass spectrometry, verifying identity and molecular mass. The most recent Retatrutide lot (92216) measured 99.726% main-peak purity. The certificate of analysis ships inside every order.
Request the current Retatrutide lot COA before you order, or browse the library.
View COA Library





